Switch to:
More From Other Websites
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting Dec 07 2016
Juno Reports Positive Phase I Study Data on Lymphoma Drug Dec 06 2016
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate Dec 05 2016
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S. Dec 01 2016
Time to Focus on Heska (HSKA) for Strong Earnings Growth Potential Nov 30 2016
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor Nov 30 2016
Coverage initiated on Heska Corp by The Benchmark Company Nov 29 2016
Jazz Completes Patient Enrollment in JZP-110 Narcolepsy Trial Nov 29 2016
Glaxo (GSK) Files Regulatory Application for Shingrix in EU Nov 28 2016
OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S. Nov 25 2016
Juno's ROCKET Study on Clinical Hold Again, Shares Down Nov 24 2016
Is Heska (HSKA) Stock a Solid Choice Right Now? Nov 23 2016
Allergan's Fibristal Approved in Canada for Label Expansion Nov 22 2016
Agios Presents Data from Dose Expansion Study of AG-120 Nov 21 2016
Apricus Biosciences Aims to Resubmit Vitaros NDA in 2017 Nov 21 2016
Earnings Estimates Moving Higher for Heska (HSKA); Time to Buy? Nov 17 2016
ACADIA Starts Phase II Schizophrenia Study on Pimavanserin Nov 16 2016
Lily's Jardiance Effective in Lowering Cardiovascular Death Nov 14 2016
HESKA CORP Financials Nov 11 2016
The Zacks Analyst Blog Highlights: Enzo Biochem, Exelixis, Genmab A/S, Heska and Incyte Nov 11 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK